This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by YANDLE, T. G. Articles by DUFF, H. Search for Related Content PubMed PubMed Citation Articles by YANDLE, T. G. Articles by DUFF, H.

Radioimmunoassay and Characterization of Atrial Natriuretic Peptide in Human Plasma^*

Department of Endocrinology, The Princess Margaret Hospital Christchurch 2 New Zealand

Address all correspondence and requests for reprints to: Prof. E. A. Espiner, Department of Endocrinology, The Princess Margaret Hospital, Cashmere Road, Christchurch 2,New Zealand.

A RIA for a-human atrial natriuretic peptide (βhANP) in plasma was developedand used to study the immunoreactive components secreted by the heart and circulating in peripheral venous plasma. The assay used [¹²⁵I]diiodotyrosylahANP, purified byhigh pressure liquid chromatography (HPLC), and a C-terminal-specific antiserum purchasedfrom Peninsula Laboratories. Serial dilution curves of coronary sinus plasma samples wereparallel with the standard curve, but significant nonparallelism was found in peripheral plasma samples of low immunoreactivity. When plasma was extracted using C-18 Sep-Pak cartridges, serial dilution curves from both coronary sinus and peripheral plasma samples were parallel to the standard curve. Although values for plasma samples assayed before and after extraction agreed closely (r = 0.99; n = 76), immunoreactive ANP in unextracted plasma was consistently greater(70-79 pmol/liter) than in extracts of plasma, suggesting nonspecific interference by a component in plasma when assayed without extraction. Mean plasma immunoreactive ANP in 19 normal subjects consuming a normal salt intake was 14 ±1 (± SE) pmol/liter. In 5 normal men, increasing dietary sodium intake from 10 to 200 mmol sodium/day was associated with a 2-fold increment in ANP levels, and similar changesaccompanied acute sodium loading using iv saline. Elevated values were found in patients with congestive heart failure (mean, 58 pmol/liter; range, 0-200; n = 9), chronic renal failure(mean, 118 pmol/liter; range, 30-290; n =8), and primary aldosteronism (range, 32-90 pmol/liter; n = 3). HPLC and gel cc harnoaml-atographi ysis of the immunoreactive material found in coronary sinus plasma extracts showed that a large amount of the materialelutedin the position of βhANP. A smaller quantity of immunoreactive material with a mol wt of about 1600was also identified. Peripheral venous plasma extracts also contained several immunoreactive components, the largest amount of which corresponded to βhANP. The patternof immunoreactive components in peripheral venous plasma, as identified by both gel chromotography and HPLC, was similar to that in coronary sinus plasma drawn during an active phase of hormone secretion.

These findings indicate that the heart secretes ahANP or a closely similar peptide which is also present in peripheral venous plasma. Plasma immunoreactive ANP is responsive to sodium loading in normal man and is elevated in patients with hypervolemic disorders.

^* This work was supported in part by the National Heart Foundation of New Zealand.

Received August 29, 1985.

This article has been cited by other articles:

				S. P. Wright, R. N. Doughty, C. M. Frampton, G. D. Gamble, T. G. Yandle, and A. M. Richards Plasma Urocortin 1 in Human Heart Failure Circ Heart Fail, September 1, 2009; 2(5): 465 - 471. [Abstract] [Full Text] [PDF]

				H. C.G. Prosser, M. E. Forster, A. M. Richards, and C. J. Pemberton Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics Cardiovasc Res, April 1, 2009; 82(1): 40 - 50. [Abstract] [Full Text] [PDF]

				C H Strey, J M Young, J H Lainchbury, C M Frampton, M G Nicholls, A M Richards, and R S Scott Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure Heart, November 1, 2006; 92(11): 1603 - 1609. [Abstract] [Full Text] [PDF]

				M. E. Davis, A. M. Richards, M. G. Nicholls, T. G. Yandle, C. M. Frampton, and R. W. Troughton Introduction of Metoprolol Increases Plasma B-Type Cardiac Natriuretic Peptides in Mild, Stable Heart Failure Circulation, February 21, 2006; 113(7): 977 - 985. [Abstract] [Full Text] [PDF]

				M. Larsen, L. B. Colmorn, M. Bonnelycke, R. Kaaja, I. Immonen, B. Sander, and S. Loukovaara Retinal Artery and Vein Diameters during Pregnancy in Diabetic Women Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 709 - 713. [Abstract] [Full Text] [PDF]

				M. E. Davis, C. J. Pemberton, T. G. Yandle, J. G. Lainchbury, M. T. Rademaker, M. G. Nicholls, C. M. Frampton, and A. M. Richards Urocortin-1 Infusion in Normal Humans J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1402 - 1409. [Abstract] [Full Text] [PDF]

				S. P. Wright, T. C.R. Prickett, R. N. Doughty, C. Frampton, G. D. Gamble, T. G. Yandle, N. Sharpe, and M. Richards Amino-Terminal Pro-C-Type Natriuretic Peptide in Heart Failure Hypertension, January 1, 2004; 43(1): 94 - 100. [Abstract] [Full Text] [PDF]

				T. M. Sutton, R. A. H. Stewart, I. L. Gerber, T. M. West, A. M. Richards, T. G. Yandle, and A. J. Kerr Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2280 - 2287. [Abstract] [Full Text] [PDF]

				I. L. Gerber, R. A.H. Stewart, M. E. Legget, T. M. West, R. L. French, T. M. Sutton, T. G. Yandle, J. K. French, A. M. Richards, and H. D. White Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis Circulation, April 15, 2003; 107(14): 1884 - 1890. [Abstract] [Full Text] [PDF]

				J. Carstens, K. T. Jensen, P. Ivarsen, L. M. Rasmussen, and E. B. Pedersen Development of a urodilatin-specific antibody and radioimmunoassay for urodilatin in human urine Clin. Chem., April 1, 1997; 43(4): 638 - 643. [Abstract] [Full Text] [PDF]